Evogene Ltd. (TLV:EVGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
392.20
-28.30 (-6.73%)
Apr 24, 2025, 5:24 PM IDT

Evogene Market Cap

Evogene has a market cap or net worth of 25.34 million as of April 25, 2025. Its market cap has decreased by -82.39% in one year.

Market Cap
25.34M
Enterprise Value
38.02M
Revenue
31.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
392.20

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 25.34M, a decrease of -77.60%. That is a compound annual growth rate of -8.18%.

History

DateMarket Cap% Change
Apr 24, 202525.34M-46.49%
Dec 31, 202447.35M-68.75%
Dec 31, 2023151.55M64.52%
Dec 29, 202292.12M-58.37%
Dec 30, 2021221.26M-59.72%
Dec 31, 2020549.28M305.78%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 61.79B
Danel (Adir Yeoshua) 2.34B
Kamada 1.38B
Bait Bakfar 933.61M
Novolog (Pharm-Up 1966) 802.02M
Ilex Medical 703.35M
BrainsWay 623.44M
SofWave Medical 554.17M
Market Cap Rankings